Concepedia

Constance Cullen

CC

Statistics

Publications

13

Citations

729

H-Index

13

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Cincinnati

Constance Cullen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, allergy, and immunology.

Top concepts

Publications per year

1989–2021

13

Publications

13

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Colin P. Dinney, Mark B. Fisher, Neema Navai et al. · The Journal of Urology · 2013 · 120 citations · Full text

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa

B. Alexander Yi, Debra Freedholm, Nancy Widener et al. · Journal of Thrombosis and Haemostasis · 2021 · 92 citations · Full text

Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway

Michael J. Grace, Seoju Lee, Sheri Bradshaw et al. · Journal of Biological Chemistry · 2005 · 87 citations · Full text

INHALATION OF POORLY SOLUBLE PARTICLES. I. DIFFERENCES IN INFLAMMATORY RESPONSE AND CLEARANCE DURING EXPOSURE

Constance Cullen · Inhalation Toxicology · 2000 · 82 citations

, , +18

Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders

Andrew H. Talal, Ruy M. Ribeiro, Kimberly A. Powers et al. · Hepatology · 2006 · 79 citations

1–5 of 13